Link: http://uk.mobile.reuters.com/article/idUKKCN0YI2MZ?irpc=932

——————–

In several news outlets around the world, via Reuters:

“Drug companies can’t make an economic case for investing in superbug drugs,” said Erik Gordon, a professor at the University of Michigan’s Ross School of Business.

Gordon said governments and foundations need to get more involved in research and funding to spearhead efforts to combat the problem.

http://uk.mobile.reuters.com/article/idUKKCN0YI2MZ?irpc=932

At CNBC:

http://www.cnbc.com/2016/05/27/reuters-america-new-incentives-needed-to-develop-antibiotics-to-fight-superbugs.html

Erik Gordon
Ross School of Business
University of Michigan